Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5647847 | Journal of the American Academy of Dermatology | 2017 | 8 Pages |
Abstract
Topical ruxolitinib 1.5% cream provided significant repigmentation in facial vitiligo and may offer a valuable new treatment for vitiligo.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Brooke BA, Deep MBBS, MD, Ami MD, Rana MD, Huda MD, Yana MD, Vaneeta MD, Victor MD, Shiu Chung MD, Courtney RN, Nicole Dumont, Alice B. MD, PhD, David MD,